SA
LMAT icon

SpiderRock Advisors’s LeMaitre Vascular LMAT Stock Holding History

SpiderRock Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,014
Closed -$601K – 788
2024
Q1 		$601K Buy
+9,014
New +$556K 0.02% 482

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SpiderRock Advisors's LMAT Position: Q2 2024 in Review

SpiderRock Advisors sold out of LeMaitre Vascular (LMAT) in Q2 2024, closing a stake of 9,014 shares — an estimated $601K sold.

SpiderRock Advisors first reported a position in LMAT in Q1 2024 and held it in 1 quarter. The position peaked at $601K in Q1 2024. 261 funds tracked by Wall St. Rank hold LMAT as of Q2 2024.

  • SpiderRock Advisors reported no remaining LeMaitre Vascular position as of Q2 2024 after selling out during the quarter.
  • SpiderRock Advisors sold 9,014 LeMaitre Vascular shares in Q2 2024, an estimated $601K.
  • SpiderRock Advisors first reported a position in LeMaitre Vascular in Q1 2024 and held it in 1 quarter.
  • SpiderRock Advisors's LeMaitre Vascular position peaked at $601K in Q1 2024.
  • 261 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2024.

Based on SpiderRock Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.